Article
Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic
10 Sept 2021
Abstract excerpt
Prostate cancer (PC) is the second most common cancer in men worldwide. Due to the large-scale sequencing efforts, there is currently a better understanding of the genomic landscape of PC. The identification of defects in DNA repair genes has led to clinical studies that provide a strong rationale for developing poly (ADP-ribose) polymerase (PARP) inhibitors and DNA-damaging agents in this molecularly defined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
